Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Celgene Corp (NQ: CELG)
124.91 USD  +1.43 (+1.16%)
Official Closing Price  /  Updated: 8:10 PM EDT, May 17, 2013  /  Add to My Watchlist      
View: Quote News Research
Press releases about Celgene Corp
 
< Previous 1 2 3 4 5 6 7 8 9
...
20 21 Next >
ABRAXANE® Plus Gemcitabine Demonstrates Significant Survival Advantage in Phase III Study of Patients with Advanced Pancreatic Cancer
January 22, 2013
from Business Wire News Releases
Critical Alerts For Applied Materials, Celgene, Abercrombie & Fitch, TD Ameritrade, and Edwards Lifesciences Released By InvestorsObserver
January 22, 2013
from PR Newswire
The Reason It Trades, What's Moving CELG, LULU, PRAA and WPI
January 16, 2013
from Marketwired News Releases
Which Biotech Companies Are Turning the Tables on Patent Cliffs?
January 14, 2013
from PR Newswire
Perfect Trade Setups, How to Play CELG, NVS, GSK and BMY
January 14, 2013
from Marketwired News Releases
Top Stock Alerts for Day Traders: Verizon, Goldcorp, Celgene, Alpha Natural Resources, American International Group, and AbbVie
January 09, 2013
from PR Newswire
Free Research Reports on CELG, GME, GNW and YUM Issued by the Bedford Report
January 09, 2013
Note to Editors: The Following Is an Investment Opinion Being Issued by the Equity News Circuit Read More
from Marketwired News Releases
The Real Story Behind TISI, LNN, SIG and CELG
January 09, 2013
from Marketwired News Releases
NASDAQ Stocks on the News: (NASDAQ: CELG), (NASDAQ: SPWR)
January 08, 2013
from SBWire Direct - Latest Press Releases
CELG, DHR, DDD and BCS Freshly Hit a New 52-Week High
January 08, 2013
from Marketwired News Releases
Free Research Reports on BIOL, CELG, ILMN and HAR Issued by the Bedford Report
January 08, 2013
Note to Editors: The Following Is an Investment Opinion Being Issued by the Equity News Circuit Read More
from Marketwired News Releases
Celgene Corporation Announces Financial Outlook and Preliminary 2012 Results
January 07, 2013
from Business Wire News Releases
Celgene Corporation to Present at the 31st Annual J.P. Morgan Healthcare Conference
December 21, 2012
from Business Wire News Releases
Critical Alerts For Pfizer, Celgene, D.R. Horton, TripAdvisor, and Equifax Released By InvestorsObserver
December 18, 2012
from PR Newswire
Celgene Corporation to Webcast at an Upcoming Investor Conference and the 54th American Society of Hematology Annual Meeting
November 28, 2012
from Business Wire News Releases
Apremilast oral logra resultados estadísticamente significativos para el criterio de valoración principal ACR20 en el primer ensayo de Fase III (PALACE-1) en pacientes con artritis psoriásica
November 14, 2012
from Business Wire Spanish
Oral Apremilast Achieves Statistical Significance for the Primary Endpoint of ACR20 in the First Phase III Study (PALACE-1) in Patients with Psoriatic Arthritis
November 13, 2012
from Business Wire News Releases
Critical Alerts For Abercrombie, Best Buy, Caterpillar, Celgene, and VMware Released By InvestorsObserver
November 13, 2012
from PR Newswire
Earnings Forecast Stock Alerts: Gilead Sciences, Citigroup, Hewlett-Packard, Celgene, JPMorgan, and Sirius
November 13, 2012
from PR Newswire
Breaking News on Top Traded Stocks: Citigroup, Celgene, QUALCOMM, Mylan, Western Union, and Dow Chemical
November 13, 2012
from PR Newswire
ABRAXANE® muestra una mejoría estadísticamente significativa en la supervivencia general para los pacientes con cáncer pancreático avanzado en el ensayo de fase III
November 10, 2012
from Business Wire Spanish
ABRAXANE® Demonstrates Statistically Significant Improvement in Overall Survival for Patients with Advanced Pancreatic Cancer in Phase III Study
November 09, 2012
from Business Wire News Releases
Celgene Corporation to Webcast at Two Upcoming Investor Conferences and the American College of Rheumatology
November 07, 2012
from Business Wire News Releases
Factors of Influence, Economy and Policy -- Research & Analysis on Celgene Corporation and Teva Pharmaceutical Industries Limited
October 26, 2012
from Marketwired News Releases
ABRAXANE® demuestra una mejora significativa en la supervivencia libre de progresión en comparación con la quimioterapia estándar en pacientes con melanoma avanzado
October 25, 2012
from Business Wire Spanish
Celgene Reports Third Quarter 2012 Operating and Financial Results
October 25, 2012
from Business Wire News Releases
ABRAXANE® Demonstrates Significant Improvement in Progression-Free Survival Compared to Standard Chemotherapy in Advanced Melanoma Patients
October 25, 2012
from Business Wire News Releases
Celgene and NPS Pharmaceuticals Shares Surge on Positive FDA News
October 16, 2012
Five Star Equities Provides Stock Research on Celgene and NPS Pharmaceuticals Read More
from Marketwired News Releases
RBCC: Could Stem Cells Be Key to Promising Autism Therapy?
October 16, 2012
from Business Wire News Releases
FDA Approves ABRAXANE® for the First-Line Treatment of Advanced Non-Small Cell Lung Cancer
October 12, 2012
from Business Wire News Releases
< Previous 1 2 3 4 5 6 7 8 9
...
20 21 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here